Companies / Financials
MSCI
MSCI
Financial Exchanges & Data
Financial Exchanges & DataAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health84
Growth61
Profitability100
Cash generationn/a
Balance sheetn/a
Dilution control92
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)12.4%Revenue growth (FY)9.7%Revenue CAGR (3y)11.7%Gross margin—Operating margin54.7%Net margin38.4%Free cash flow margin49.4%R&D / revenue5.7%Stock comp / revenue3.6%Net debt / operating cash flow3.58xCurrent ratio0.90Diluted share count change-2.9%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $2.0B | $2.2B | $2.5B | $2.9B | $3.1B |
| Operating income | $1.1B | $1.2B | $1.4B | $1.5B | $1.7B |
| Net income | $726M | $871M | $1.1B | $1.1B | $1.2B |
| Operating cash flow | $936M | $1.1B | $1.2B | $1.5B | $1.6B |
| Capital expenditure | $14M | $14M | $23M | $34M | $39M |
| Free cash flow | $923M | $1.1B | $1.2B | $1.5B | $1.5B |
| R&D | $112M | $107M | $132M | $159M | $178M |
| Stock-based comp | $55M | $58M | $72M | $95M | $111M |
| Buybacks | $198M | $1.4B | $504M | $885M | $2.5B |
| Dividends | $302M | $373M | $441M | $509M | $557M |
| Cash | $1.4B | $994M | $462M | $409M | $515M |
| Total debt | $4.2B | $4.5B | $4.5B | $4.5B | $6.2B |
| Equity | -$163M | -$1.0B | -$740M | -$940M | -$2.7B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.